Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease

Cevat Kirma1, Mustafa Akcakoyun, Ali Metin Esen

  • 1Department of Cardiology, Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital, Istanbul, Turkey.

Insights

Aging and diabetes mellitus are the primary drivers of endothelial dysfunction in patients with coronary artery disease. These factors significantly impact blood vessel health even when coronary artery disease is already present.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Clinical Research

Background:

  • Coronary artery disease (CAD) and its risk factors are linked to endothelial dysfunction.
  • Understanding which risk factors persist in contributing to dysfunction in established CAD is crucial.

Purpose of the Study:

  • To identify which coronary artery disease risk factors independently contribute to endothelial dysfunction in patients with existing CAD.

Main Methods:

  • 150 CAD patients underwent high-resolution ultrasound to measure brachial artery diameter.
  • Flow-mediated dilatation (FMD%) and nitroglycerin-induced dilatation (NTG%) were assessed.
  • Relationships between FMD% and various risk factors (diabetes, lipids, age, BMI, smoking, hypertension, family history) were analyzed.

Main Results:

  • Univariate analysis showed inverse correlations between FMD% and age, BMI, with lower FMD% in diabetic patients.
  • Multivariate regression revealed that only advanced age and diabetes mellitus (DM) remained independently associated with endothelial dysfunction.
  • Hypercholesterolemia, hypertension, smoking, and family history did not show significant associations with FMD% in established CAD.

Conclusions:

  • Aging and diabetes mellitus are independently associated with endothelial dysfunction in patients with established coronary artery disease.
  • Other traditional CAD risk factors do not independently contribute to endothelial dysfunction in this patient group.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...